{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Estimar a preval\u00eancia e os fatores associados ao uso de metilfenidato para neuroaprimoramento entre estudantes universit\u00e1rios.",
        "Amostra aleat\u00f3ria simples de discentes da Universidade Federal de Minas Gerais (n=438), convidados a responder um question\u00e1rio online sobre o consumo de metilfenidato. A coleta ocorreu de setembro de 2014 a janeiro de 2015. A amostra foi descrita em termos de propor\u00e7\u00f5es, m\u00e9dias e desvio padr\u00e3o. A an\u00e1lise multivariada foi realizada utilizando o algoritmo <i>Classification and Regression Tree</i> para classifica\u00e7\u00e3o dos casos de uso do metilfenidato para neuroaprimoramento em grupos, com base nas vari\u00e1veis de exposi\u00e7\u00e3o.",
        "Dos 378 alunos inclu\u00eddos, 5,8% (n=22) declararam ter feito uso de metilfenidato para neuroaprimoramento, sendo 41% (9/22) nas 4 semanas anteriores \u00e0 pesquisa. A situa\u00e7\u00e3o da moradia foi a vari\u00e1vel mais associada ao uso de metilfenidato para neuroaprimoramento. Relataram o uso do metilfenidato para neuroaprimoramento e outros fins nas 4 semanas anteriores \u00e0 pesquisa 11 estudantes, sendo que 27% n\u00e3o apresentaram prescri\u00e7\u00e3o m\u00e9dica para adquiri-lo.",
        "O uso de metilfenidato para neuroaprimoramento ocorre no meio acad\u00eamico brasileiro e deve ser considerado s\u00e9rio problema de sa\u00fade p\u00fablica, principalmente diante dos riscos de danos e efeitos adversos associados ao seu uso."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31664322",
  "DateCompleted": {
    "Year": "2019",
    "Month": "11",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "10",
        "Day": "24"
      }
    ],
    "Language": [
      "eng",
      "por"
    ],
    "ELocationID": [
      "eAO4745",
      "10.31744/einstein_journal/2020AO4745",
      "S1679-45082020000100205"
    ],
    "Journal": {
      "ISSN": "2317-6385",
      "JournalIssue": {
        "Volume": "18",
        "PubDate": {
          "Year": "2019"
        }
      },
      "Title": "Einstein (Sao Paulo, Brazil)",
      "ISOAbbreviation": "Einstein (Sao Paulo)"
    },
    "ArticleTitle": "Prevalence of and factors associated with the use of methylphenidate for cognitive enhancement among university students.",
    "Pagination": {
      "StartPage": "eAO4745",
      "MedlinePgn": "eAO4745"
    },
    "Abstract": {
      "AbstractText": [
        "To estimate the prevalence of and factors associated with the use of methylphenidate for cognitive enhancement among undergraduate students.",
        "Simple random sample of students of the Universidade Federal de Minas Gerais (n=438), invited to answer an online questionnaire about the use of methylphenidate. Data collection occurred from September 2014 to January 2015. The sample was described by means of proportions, means and standard deviations. A multivariate analysis was performed using the Classification and Regression Tree algorithm to classify the cases of use of methylphenidate for cognitive enhancement in groups, based on the exposure variables.",
        "Out of 378 students included, 5.8% (n=22) reported using methylphenidate for cognitive enhancement; in that, 41% (9/22) in the 4 weeks prior to the survey. The housing situation was the variable most often associated with the use of methylphenidate for cognitive enhancement. Eleven students reported using methylphenidate for cognitive enhancement and other purposes 4 weeks prior to the survey, 27% of whom had no medical prescription to purchase it.",
        "The use of methylphenidate for cognitive enhancement is frequent among Brazilian undergraduate students and should be considered a serious public health problem, especially due to risks of harm and adverse effects associated with its use."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-5353-8125"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil."
          }
        ],
        "LastName": "C\u00e2ndido",
        "ForeName": "Raissa Carolina Fonseca",
        "Initials": "RCF"
      },
      {
        "Identifier": [
          "0000-0001-8833-9815"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil."
          }
        ],
        "LastName": "Perini",
        "ForeName": "Edson",
        "Initials": "E"
      },
      {
        "Identifier": [
          "0000-0001-7083-3188"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil."
          }
        ],
        "LastName": "P\u00e1dua",
        "ForeName": "Cristiane Menezes de",
        "Initials": "CM"
      },
      {
        "Identifier": [
          "0000-0002-3261-4811"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil."
          }
        ],
        "LastName": "Junqueira",
        "ForeName": "Daniela Rezende",
        "Initials": "DR"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Brazil",
    "MedlineTA": "Einstein (Sao Paulo)",
    "NlmUniqueID": "101281800",
    "ISSNLinking": "1679-4508"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Central Nervous System Stimulants"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nootropic Agents"
    },
    {
      "RegistryNumber": "207ZZ9QZ49",
      "NameOfSubstance": "Methylphenidate"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Brazil"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Central Nervous System Stimulants"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross-Sectional Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Decision Trees"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Methylphenidate"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Nootropic Agents"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Off-Label Use"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Residence Characteristics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Socioeconomic Factors"
    },
    {
      "QualifierName": [
        "psychology",
        "statistics & numerical data"
      ],
      "DescriptorName": "Students"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Surveys and Questionnaires"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Universities"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "Conflict of interest: none."
}